97 related articles for article (PubMed ID: 7335622)
1. [Prolonged QT interval and "torsades de pointes" after therapy with prenylamin (Segontin) (author's transl)].
Burri C; Ajdacic K; Michot F
Schweiz Rundsch Med Prax; 1981 Apr; 70(16):717-20. PubMed ID: 7335622
[No Abstract] [Full Text] [Related]
2. [A case of prenylamine syncope (torsades de pointes)].
Oda E; Takeda K; Ohno T; Nagai T; Shibuya T; Aizawa Y; Arai Y; Ozawa T; Shibata A
Kokyu To Junkan; 1985 Mar; 33(3):453-8. PubMed ID: 4012076
[No Abstract] [Full Text] [Related]
3. Mexiletine: long-term follow-up of a patient with prolonged QT interval and quinidine-induced torsades de pointes.
Thomas MG; Giles TD
South Med J; 1985 Feb; 78(2):205-6. PubMed ID: 3919448
[TBL] [Abstract][Full Text] [Related]
4. Possible female preponderance in prenylamine-induced 'torsade de pointes' tachycardia. Short communication.
Abinader EG; Shahar J
Cardiology; 1983; 70(1):37-40. PubMed ID: 6850685
[TBL] [Abstract][Full Text] [Related]
5. [Verapamil and torsade de pointe (author's transl)].
Fanelli R; Piemontese M; Di Michele M; De Matteis D
G Ital Cardiol; 1979; 9(9):1028-9. PubMed ID: 520732
[TBL] [Abstract][Full Text] [Related]
6. [Prolonged Q-T interval, syncope and prenylamine].
Fazzini PF; Marchi F; Pucci P
G Ital Cardiol; 1973; 3(2):233-9. PubMed ID: 4123358
[No Abstract] [Full Text] [Related]
7. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia].
Lengyel C; Várkonyi T; Fazekas T
Orv Hetil; 1997 Apr; 138(16):1003-6. PubMed ID: 9153994
[TBL] [Abstract][Full Text] [Related]
8. A case of prenylamine toxicity showing the torsade de pointes phenomenon in sinus rhythm?
Meanock CI; Noble MI
Postgrad Med J; 1981 Jun; 57(668):381-4. PubMed ID: 7301686
[TBL] [Abstract][Full Text] [Related]
9. [Takotsubo cardiomyopathy associated with torsades de pointes and long QT interval: a case report].
Okada T; Miyata S; Hashimoto K; Maie K; Mochizuki S
J Cardiol; 2007 Jul; 50(1):83-8. PubMed ID: 17685032
[TBL] [Abstract][Full Text] [Related]
10. Torsade de pointes due to prenylamine controlled by lignocaine.
Tamari I; Rabinowitz B; Neufeld HN
Eur Heart J; 1982 Aug; 3(4):389-92. PubMed ID: 7128627
[No Abstract] [Full Text] [Related]
11. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
Ly T; Ruiz ME
Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
[TBL] [Abstract][Full Text] [Related]
12. Ventricular tachycardia precipitated by sodium iothalamate (Conray 420) injection during prenylamine treatment: a predictable adverse drug interaction.
Duncan JS; Ramsay LE
Postgrad Med J; 1985 May; 61(715):415-7. PubMed ID: 4022877
[TBL] [Abstract][Full Text] [Related]
13. Prenylamine induced torsade de pointes.
Kadiwar RM; MacMahon B
Ir Med J; 1990 Dec; 83(4):163. PubMed ID: 2081677
[No Abstract] [Full Text] [Related]
14. QT interval prolongation, torsade de pointes and renal disease.
Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
[TBL] [Abstract][Full Text] [Related]
15. Torsades de pointe with prenylamine.
Mohr R
Lancet; 1986 Nov; 2(8517):1218. PubMed ID: 2877350
[No Abstract] [Full Text] [Related]
16. Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome.
Kawabata M; Hirao K; Takeshi S; Sakurai K; Inagaki H; Hachiya H; Isobe M
J Electrocardiol; 2008; 41(2):117-22. PubMed ID: 18328336
[TBL] [Abstract][Full Text] [Related]
17. Torsade de pointes with prenylamine: do we still need the drug?
Fraser AG; Ikram S
Lancet; 1986 Sep; 2(8506):572. PubMed ID: 2875301
[No Abstract] [Full Text] [Related]
18. [A case of cardiac arrest after torsades de pointes due to prolonged QT interval syndrome possibly associated with subarachnoid hemorrhage].
Yamaguchi S; Watanabe K; Mishio M; Okuda Y; Kitajima T
Masui; 1999 Jun; 48(6):644-6. PubMed ID: 10402818
[TBL] [Abstract][Full Text] [Related]
19. Torsade de pointes: the clinical considerations.
Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
[TBL] [Abstract][Full Text] [Related]
20. Prenylamine-induced ventricular tachycardia and syncope controlled by ventricular pacing.
Grenadier E; Keidar S; Alpan G; Marmor A; Palant A
Br Heart J; 1980 Sep; 44(3):330-4. PubMed ID: 7426190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
